← Eichor
Condition: Lung Node Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lung Node

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)
NA · 1 location(s) · Fudan University · NCT04527419Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC
NA · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT04631770Radical Resection With Contralateral Lymph Node Dissection for Clinical N3 NSCLC
NA · 2 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT07003490Bronchial NIR Image-guided Resection
Phase 1/Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT03097575Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma
Phase N/A · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT05830812Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)
Phase 3 · 1 location(s) · Fudan University · NCT06031246Chest Lymph Node Sampling in Patients With Advanced Lung Cancer to be Treated With Curative-intent Radiation Treatment
NA · 2 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT04852588Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment
Phase N/A · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT05426135Molecular Signature From Tumor to Lymph Nodes
Phase N/A · 12 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04677205InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796Detection of Genetic Markers of Lung Cancer
Phase N/A · 1 location(s) · University of Pittsburgh · NCT00280202Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cm
NA · 1 location(s) · Fudan University · NCT06634979Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node
Phase 2 · 3 location(s) · Georgetown University · NCT06449313Sarcoidosis and Immune Cells in Lung, Lymph Nodes and Blood
NA · 1 location(s) · Region Stockholm · NCT05751447Shortened Regimen for Drug-susceptible TB in Children
Phase 3 · 9 location(s) · Johns Hopkins University · NCT06253715Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagn
Phase N/A · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06653478Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decis
Phase N/A · 1 location(s) · Fudan University · NCT06684418Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence
Phase N/A · 2 location(s) · Norwegian University of Science and Technology · NCT05739331Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules
NA · 1 location(s) · University Hospital, Toulouse · NCT05306912Cardiovascular Risk in Children With Chronic Conditions Study
Phase N/A · 3 location(s) · Semmelweis University · NCT07086989Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion
Phase N/A · 1 location(s) · Luzerner Kantonsspital · NCT05596578A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcin
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07063888Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell
NA · 1 location(s) · University Health Network, Toronto · NCT01786590The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Predictio
NA · 1 location(s) · St. Joseph's Healthcare Hamilton · NCT06540196Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca
Phase N/A · 51 location(s) · Duke University · NCT04278404A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After
Phase 2 · 33 location(s) · Alliance for Clinical Trials in Oncology · NCT07293247Lymph Node Pathologic Grading Strategy
Phase N/A · 1 location(s) · Fudan University · NCT06745830Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC
Phase 2 · 1 location(s) · Yang Hong · NCT07309952Ultrasound-guided Cryobiopsy of Mediastinal/Hilar Lymph Nodes
NA · 1 location(s) · University of Zurich · NCT06921681Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens
NA · 1 location(s) · Brigham and Women's Hospital · NCT06252129
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.